Palisade Bio Inc stock is traded at $1.12, with a volume of 1,460,064. It is down -1.75% in the last 24 hours and down -20.57% over the past month. Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Previous Close:
$1.14
Open:
$1.15
24h Volume:
1,460,064
Relative Volume:
0.40
Market Cap:
$201.02M
Revenue:
$250.00K
Net Income/Loss:
-$24.15M
P/E Ratio:
-
EPS:
-$1.07
Net Cash Flow:
-$12.40M
1W Performance:
-5.88%
1M Performance:
-20.57%
6M Performance:
-38.80%
1Y Performance:
-47.66%
1-Day Range:
$1.08$1.15
1-Week Range:
$1.08$1.20
52-Week Range:
$1.08$2.86
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 704-4900Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS